Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$848M |
| 2 |
Tesla
TSLA
|
+$759M |
| 3 |
Home Depot
HD
|
+$653M |
| 4 |
Meta Platforms (Facebook)
META
|
+$567M |
| 5 |
Wells Fargo
WFC
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$409M |
| 3 |
Micron Technology
MU
|
+$379M |
| 4 |
AT&T
T
|
+$372M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.03% |
| 2 | Technology | 14.98% |
| 3 | Consumer Discretionary | 11.43% |
| 4 | Consumer Staples | 10.71% |
| 5 | Communication Services | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICPT
1826
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $3.5M | ﹤0.01% |
215,200
-28,369
| -12% | -$444K |
|
|
AYX
1827
DELISTED
Alteryx Inc
AYX
| $3.5M | ﹤0.01% |
+48,900
| New | +$2.89M |
|
1828
American Outdoor Brands
AOUT
$160M
| $3.48M | ﹤0.01% |
265,335
-88,233
| -25% | -$1.42M |
|
|
ASAI
1829
DELISTED
Sendas Distribuidora S.A. American Depositary Share (each representing five common shares)
ASAI
| $3.48M | ﹤0.01% |
202,400
-9,400
| -4% | -$119K |
|
1830
Cousins Properties
CUZ
$4.89B
| $3.47M | ﹤0.01% |
86,231
-113,600
| -57% | -$4.48M |
|
1831
Novanta
NOVT
$6.3B
| $3.47M | ﹤0.01% |
+24,400
| New | +$3.46M |
|
|
ALPN
1832
DELISTED
Alpine Immune Sciences Inc
ALPN
| $3.46M | ﹤0.01% |
386,094
-200
| -0.1% | -$1.73K |
|
1833
Airgain
AIRG
$72.2M
| $3.46M | ﹤0.01% |
456,626
-4,056
| -0.9% | -$37.1K |
|
1834
TPG
TPG
$8.51B
| $3.45M | ﹤0.01% |
+114,500
| New | +$3.54M |
|
1835
Ampco-Pittsburgh
AP
$194M
| $3.45M | ﹤0.01% |
546,401
-35,100
| -6% | -$211K |
|
1836
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.48B
| $3.43M | ﹤0.01% |
91,000
+27,809
| +44% | +$1.07M |
|
1837
Jack in the Box
JACK
$325M
| $3.43M | ﹤0.01% |
+36,700
| New | +$3.25M |
|
1838
Amcor
AMCR
$21.3B
| $3.43M | ﹤0.01% |
60,134
-665,946
| -92% | -$38.9M |
|
1839
Teradata
TDC
$2.57B
| $3.42M | ﹤0.01% |
69,300
-599,300
| -90% | -$27.5M |
|
1840
Seres Therapeutics
MCRB
$45.6M
| $3.41M | ﹤0.01% |
23,970
-13,355
| -36% | -$2.05M |
|
1841
Air T
AIRT
$79.2M
| $3.41M | ﹤0.01% |
149,811
-9,900
| -6% | -$240K |
|
1842
OptimizeRx
OPRX
$164M
| $3.39M | ﹤0.01% |
90,000
+81,300
| +934% | +$3.6M |
|
1843
iShares MSCI Indonesia ETF
EIDO
$489M
| $3.39M | ﹤0.01% |
137,100
+65,300
| +91% | +$1.56M |
|
1844
Silvercrest Asset Management
SAMG
$79.6M
| $3.39M | ﹤0.01% |
165,908
-38,641
| -19% | -$690K |
|
1845
Clover Health Investments
CLOV
$2.44B
| $3.39M | ﹤0.01% |
+954,800
| New | +$2.77M |
|
1846
BRC Group Holdings
RILY
$299M
| $3.39M | ﹤0.01% |
48,439
+5,700
| +13% | +$386K |
|
1847
Lantronix
LTRX
$289M
| $3.38M | ﹤0.01% |
506,794
-329,000
| -39% | -$2.34M |
|
1848
iShares Fallen Angels USD Bond ETF
FALN
$1.61B
| $3.38M | ﹤0.01% |
121,768
+113,168
| +1,316% | +$3.21M |
|
1849
dLocal
DLO
$4.17B
| $3.38M | ﹤0.01% |
+108,000
| New | +$3.26M |
|
1850
Omega Flex
OFLX
$289M
| $3.37M | ﹤0.01% |
25,980
| – | – |
|
Similar funds
Jim Simons's Q1 2022 Portfolio in Review
As of Q1 2022, Jim Simons held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.
- Jim Simons's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
- Jim Simons added most to Tesla in Q1 2022, an estimated $759M increase.
- Jim Simons's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
- Jim Simons fully exited Microsoft in Q1 2022, selling an estimated $786M.
- Jim Simons's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
- Jim Simons opened 822 new positions and closed 650 in Q1 2022.
- Jim Simons's portfolio value rose 6% quarter-over-quarter to $85.2B.
Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.